Single-dose systemic methotrexatevsexpectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial-Reference-Cited by-同舟云学术

Single-dose systemic methotrexatevsexpectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial

Author:

Jurkovic D.¹,Memtsa M.¹,Sawyer E.²,Donaldson A. N. A.³,Jamil A.¹,Schramm K.²,Sana Y.²,Otify M.²,Farahani L.¹,Nunes N.¹^ORCID,Ambler G.⁴,Ross J. A.²

Affiliation:

1. Institute for Women's Health; University College Hospital; London UK

2. Early Pregnancy Unit, Department of Obstetrics and Gynaecology; King's College Hospital; London UK

3. Applied Mathematics & Statistics Department; State University of New York; Stony Brook NY USA

4. Department of Statistical Science; University College London; London UK

Publisher

Wiley

Subject

Obstetrics and Gynaecology,Radiology Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Link

Reference16 articles.

1. Interventions for tubal ectopic pregnancy;Hajenius;Cochrane Database Syst Rev,2007

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Prognostic factors for spontaneous resolution of an ectopic pregnancy;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-12

4. Gestörte Frühgravidität;Frauenheilkunde up2date;2023-12